Dr. Brianne Kent, a postdoctoral fellow working under the supervision of Dr. Haakon Nygaard at the University of British Columbia, is one of four recipients of the 2016-17 Banting Postdoctoral Fellowship within the Faculty of Medicine. GrantsAwardsFellowshipsScholarships Grants Winner Grant Link to Article Dr. Robert Carruthers VCHRI Team Grant Award Read More Dr. Saraswathi Vedum VCHRI Team Grant Award Read…
Read More
Alternative transcription start site (TSS) usage plays important roles in transcriptional control of mammalian gene expression. The growing interest in alternative TSSs and their role in genome diversification spawned many single-gene studies on differential usages of tissue-specific or temporal-specific alternative TSSs. However, exploration of the switching usage of alternative TSS usage on a genomic level, especially in the central nervous…
Read More
Cardiome Pharma Corp. today announced that it received authorization from Health Canada to begin selling BRINAVESS® (vernakalant hydrochloride, IV) and has subsequently launched BRINAVESS® in Canada. BRINAVESS® is indicated for the rapid conversion of recent onset atrial fibrillation (“AF”) to sinus rhythm for: non-surgery patients with AF < 7 days; and post-cardiac surgery patients with duration of AF < 3…
Read More
The separation of sarcomatoid and desmoplastic malignant mesotheliomas from sarcomatoid carcinomas of the lung metastatic to the pleura may be difficult, since both types of tumor can be morphologically similar and are frequently positive only for pan-keratin. GATA binding protein 3 (GATA3) is most commonly used as an immunohistochemical marker of breast and urothelial carcinoma, but is also known to…
Read More

To Improve Access to Science Funding, Support the Report

On April 10, 2017, the Fundamental Science Review was released to the public. Written by nine experts in science and technology, the review of federal support for science was commissioned by the Minister of Science, The Honourable Kristy Duncan and included a review of all disciplines, basic and applied, that involved federal support and peer-review, as well as a review…
Read More
Accenture and quantum software firm 1QBit collaborated with Biogen to develop a first-of-its-kind quantum-enabled molecular comparison application that could significantly improve advanced molecular design to speed up drug discovery for complex neurological conditions such as multiple sclerosis, Alzheimer’s, Parkinson’s and Lou Gehrig’s Disease. Researchers at Accenture Labs collaborated with 1QBit to create the new application which enhances Biogen’s existing molecule…
Read More
Read the Publication  This week we profile a recent publication in Oncotarget from the laboratory of Dr. Xiaoyan Jiang (centre) at the Terry Fox Laboratories. Can you provide a brief overview of your lab’s current research focus? The focus of our translational leukemia research is to identify key molecules and pathways that will lead to new, rationally designed, more effective,…
Read More
The BC Tech Association is committed to making BC the best place to build a tech company through programs that help organizations collaborate, learn and grow together. Last night in Vancouver, they announced this year’s Technology Impact Awards winners. Since 1993, the tech industry has quintupled to nearly $26 billion in revenue that includes 9,000 companies, employing more than 150,000…
Read More
The effect of age at first dose on the immunogenicity of a two-dose pediatric schedule of Measles-Mumps-Rubella (MMR) or MMR-Varicella (MMRV) vaccines was assessed in children born to mostly vaccinated mothers. Immunogenicity data among children given their first measles vaccine dose between 11 and 22 months of age were pooled from five randomized controlled trials conducted in Europe and the…
Read More
Aequus Pharmaceuticals Inc. a specialty pharmaceutical company with a focus on developing, advancing and promoting differentiated products, announced today that is has filed a Clinical Trial Application (“CTA”) with Health Canada in preparation for a Proof of Concept clinical study for its long-acting transdermal anti-nausea patch, AQS1303, containing the combination of pyridoxine and doxylamine (the active ingredients in Diclegis®/Diclectin®). Upon approval…
Read More